Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Effectiveness and safety with tenofovir alafenamide (TAF) for hepatitis B in US clinical practice Curry, M., Bae, H., Dieterich, D., Ankoma-Sey, V., Reddy, R., Pan, C., Hann, H., Tong, M., Kim, W., Kwo, P., Frazier, L., Milligan, S., Spitz, K., Afdhal, N. ELSEVIER SCIENCE BV. 2019: E462
View details for Web of Science ID 000463481701494